TGM2 and myelodysplastic syndrome: Finally, the autophagic TGM2 gene was upregulated in both groups of MDSs compared to healthy controls; in detail, fold change compared to controls was 2.04 in lower-risk MDS and 2.32 in higher-risk MDS, respectively.